Literature DB >> 21351142

Gsα activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus.

Celia Zazo1, Susanne Thiele, Cesar Martín, Eduardo Fernandez-Rebollo, Lorea Martinez-Indart, Ralf Werner, Intza Garin, Olaf Hiort, Guiomar Perez de Nanclares.   

Abstract

In pseudohypoparathyroidism (PHP), PTH resistance results from impairment of signal transduction of G protein-coupled receptors caused by a deficiency of the Gsα-cAMP signaling cascade due to diminished Gsα activity in maternally imprinted tissues. In PHP-Ia, inactivating mutations of the GNAS gene lead to haploinsufficiency in some tissues with biallelic expression, so in addition to PHP, Albright's hereditary osteodystrophy (AHO) is also present. In PHP-Ib, caused by methylation defects at the GNAS locus, diminished Gsα activity was thought to be limited to maternally imprinted tissues, such as the renal proximal tubule and the thyroid, leading to a lack of AHO. Recently, we demonstrated methylation defects in patients with AHO signs, indicating a connection between epigenetic changes and AHO. Our objective was to determine Gsα activity in erythrocyte membranes in patients with epigenetic defects at the GNAS locus compared to normal controls and patients with inactivating GNAS mutations. Gsα activity and expression, mutation of the GNAS locus, and methylation status were studied in patients with PHP and mild signs of AHO (PHP-Ia: 12; PHP-Ib: 17, of which 8 had some features of AHO). Then, we statistically compared the Gsα activity of the different PHP subtypes. Patients with methylation defects at the GNAS locus show a significant decrease in erythrocyte Gsα activity compared to normal controls (PHP-Ib versus controls, p < .001). This was significantly lower in patients with AHO signs (PHP-Ib + mild-AHO versus PHP-Ib, p < .05). Our research shows that PHP-Ia and PHP-Ib classification is not only overlapped genetically, as reported, but also in terms of Gsα activity. Reduced expression of GNAS due to methylation defects could downregulate Gsα activity in other tissues beyond those described and could also be causative of AHO.
Copyright © 2011 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21351142     DOI: 10.1002/jbmr.369

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  23 in total

1.  Analysis of Multiple Families With Single Individuals Affected by Pseudohypoparathyroidism Type Ib (PHP1B) Reveals Only One Novel Maternally Inherited GNAS Deletion.

Authors:  Rieko Takatani; Angelo Molinaro; Giedre Grigelioniene; Olta Tafaj; Tomoyuki Watanabe; Monica Reyes; Amita Sharma; Vibha Singhal; F Lucy Raymond; Agnès Linglart; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-11-14       Impact factor: 6.741

2.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

3.  Madelung-like deformity in pseudohypoparathyroidism type 1b.

Authors:  Janine Sanchez; Erasmo Perera; Suzanne Jan de Beur; Changlin Ding; Anna Dang; Gary D Berkovitz; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2011-07-13       Impact factor: 5.958

Review 4.  GNAS Spectrum of Disorders.

Authors:  Serap Turan; Murat Bastepe
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

5.  TSH elevations as the first laboratory evidence for pseudohypoparathyroidism type Ib (PHP-Ib).

Authors:  Angelo Molinaro; Dov Tiosano; Rieko Takatani; Dionisios Chrysis; William Russell; Nikolas Koscielniak; Marie-Laure Kottler; Patrizia Agretti; Giuseppina De Marco; Petteri Ahtiainen; Marta Christov; Outi Mäkitie; Massimo Tonacchera; Harald Jüppner
Journal:  J Bone Miner Res       Date:  2015-05       Impact factor: 6.741

Review 6.  Pseudohypoparathyroidism: one gene, several syndromes.

Authors:  O Tafaj; H Jüppner
Journal:  J Endocrinol Invest       Date:  2016-12-19       Impact factor: 4.256

Review 7.  An update on the clinical and molecular characteristics of pseudohypoparathyroidism.

Authors:  Michael A Levine
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-12       Impact factor: 3.243

8.  European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study.

Authors:  Intza Garin; Giovanna Mantovani; Urko Aguirre; Anne Barlier; Bettina Brix; Francesca M Elli; Kathleen Freson; Virginie Grybek; Benedetta Izzi; Agnès Linglart; Guiomar Perez de Nanclares; Caroline Silve; Susanne Thiele; Ralf Werner
Journal:  Eur J Hum Genet       Date:  2014-07-09       Impact factor: 4.246

9.  Genetic and Epigenetic Defects at the GNAS Locus Lead to Distinct Patterns of Skeletal Growth but Similar Early-Onset Obesity.

Authors:  Patrick Hanna; Virginie Grybek; Guiomar Perez de Nanclares; Léa C Tran; Luisa de Sanctis; Francesca Elli; Javier Errea; Bruno Francou; Peter Kamenicky; Léa Linglart; Arrate Pereda; Anya Rothenbuhler; Daniele Tessaris; Susanne Thiele; Alessia Usardi; Ashley H Shoemaker; Marie-Laure Kottler; Harald Jüppner; Giovanna Mantovani; Agnès Linglart
Journal:  J Bone Miner Res       Date:  2018-06-07       Impact factor: 6.741

10.  De novo STX16 deletions: an infrequent cause of pseudohypoparathyroidism type Ib that should be excluded in sporadic cases.

Authors:  Serap Turan; Jaakko Ignatius; Jukka S Moilanen; Outi Kuismin; Helen Stewart; Nicholas P Mann; Agnès Linglart; Murat Bastepe; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2012-10-18       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.